Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screening

por Kumar, Anuradha, Chettiar, Somsundaram, Brown, Brian S., Early, Julie, Ollinger, Juliane, Files, Megan, Bailey, Mai A., Korkegian, Aaron, Dennison, Devon, McNeil, Matthew, Metz, James, Osuma, Augustine, Curtin, Michael, Kunzer, Aaron, Freiberg, Gail, Bruncko, Milan, Kempf, Dale, Parish, Tanya
Publicado 2022

Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X(L) Inhibitor

por Wang, Le, Doherty, George A., Judd, Andrew S., Tao, Zhi-Fu, Hansen, T. Matthew, Frey, Robin R., Song, Xiaohong, Bruncko, Milan, Kunzer, Aaron R., Wang, Xilu, Wendt, Michael D., Flygare, John A., Catron, Nathaniel D., Judge, Russell A., Park, Chang H., Shekhar, Shashank, Phillips, Darren C., Nimmer, Paul, Smith, Morey L., Tahir, Stephen K., Xiao, Yu, Xue, John, Zhang, Haichao, Le, Phuong N., Mitten, Michael J., Boghaert, Erwin R., Gao, Wenqing, Kovar, Peter, Choo, Edna F., Diaz, Dolores, Fairbrother, Wayne J., Elmore, Steven W., Sampath, Deepak, Leverson, Joel D., Souers, Andrew James
Publicado 2020